Literature DB >> 2065682

Standards for analysis of ventricular late potentials using high resolution or signal-averaged electrocardiography. A statement by a Task Force Committee between the European Society of Cardiology, the American Heart Association and the American College of Cardiology.

G Breithardt1, M E Cain, N el-Sherif, N Flowers, V Hombach, M Janse, M B Simson, G Steinbeck.   

Abstract

Sufficient data are available to recommend that the high-resolution or signal-averaged electrocardiogram can be used in patients recovering from myocardial infarction without bundle branch block to help to determine their risk for developing sustained ventricular tachyarrhythmias. However, no data are available regarding the extent to which pharmacologic or non-pharmacologic interventions in patients with late potentials have an impact on the incidence of sudden cardiac death. Therefore, controlled, prospective studies are required before this issue can be definitely answered. As refinements in techniques evolve, it is anticipated that the clinical value of high-resolution or signal-averaged electrocardiography will continue to increase in the future.

Entities:  

Mesh:

Year:  1991        PMID: 2065682     DOI: 10.1093/oxfordjournals.eurheartj.a059926

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  22 in total

1.  Wavelet-based enhancement of signal-averaged electrocardiograms for late potential detection.

Authors:  A Rakotomamonjy; D Coast; P Marché
Journal:  Med Biol Eng Comput       Date:  1999-11       Impact factor: 2.602

2.  Cardioplegia and ventricular late potentials in cardiac surgical patients.

Authors:  N Schütz; J-A Romand; N D Yanez; M M Treggiari; K Bendjelid
Journal:  J Clin Monit Comput       Date:  2011-09-20       Impact factor: 2.502

3.  Signal-averaged electrocardiography in normal newborn infants.

Authors:  R G Bennhagen; L Sörnmo; O Pahlm; E Pesonen
Journal:  Pediatr Cardiol       Date:  2004-04-19       Impact factor: 1.655

4.  Sudden death is associated with a widened paced QRS complex in noncoronary cardiac disease.

Authors:  Per Otto Schueller; Marcus Guenter Hennersdorf; Bodo Eckehard Strauer
Journal:  J Interv Card Electrophysiol       Date:  2006-03       Impact factor: 1.900

5.  [Commentary on the guidelines the diagnosis and the therapy of syncope--the European Society of Cardiology 2001 and the update 2004].

Authors:  K Seidl; A Schuchert; J Tebbenjohanns; W Hartung
Journal:  Z Kardiol       Date:  2005-09

Review 6.  The perils of surrogate endpoints.

Authors:  William S Weintraub; Thomas F Lüscher; Stuart Pocock
Journal:  Eur Heart J       Date:  2015-05-13       Impact factor: 29.983

7.  Correlation between the parameters of signal-averaged ECG and two-dimensional echocardiography in patients with arrhythmogenic right ventricular cardiomyopathy.

Authors:  Yongwhi Park; Yongkeun Cho; Dong-Yeub Lee; Gui-Lyen Jang; Hyunsang Lee; Dong Heon Yang; Hun-Sik Park; Shung-Chull Chae; Jae-Eun Jun; Wee-Hyun Park
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-01       Impact factor: 1.468

8.  Later potentials on signal-averaged electrocardiograms in children after right ventriculotomy.

Authors:  L Rovamo; M Mäkijärvi; E Pesonen; E I Wallgren; L Toivonen
Journal:  Pediatr Cardiol       Date:  1995 May-Jun       Impact factor: 1.655

9.  Electrophysiologic Substrate and Risk of Mortality in Incident Hemodialysis.

Authors:  Larisa G Tereshchenko; Esther D Kim; Andrew Oehler; Lucy A Meoni; Elyar Ghafoori; Tejal Rami; Maggie Maly; Muammar Kabir; Lauren Hawkins; Gordon F Tomaselli; Joao A Lima; Bernard G Jaar; Stephen M Sozio; Michelle Estrella; W H Linda Kao; Rulan S Parekh
Journal:  J Am Soc Nephrol       Date:  2016-04-29       Impact factor: 10.121

10.  Prognostic significance of electrical alternans versus signal averaged electrocardiography in predicting the outcome of electrophysiological testing and arrhythmia-free survival.

Authors:  A A Armoundas; D S Rosenbaum; J N Ruskin; H Garan; R J Cohen
Journal:  Heart       Date:  1998-09       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.